Journey Medical Corporation Submits New Drug Application to
If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema ...
Read moreIf approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema ...
Read moreTAIPEI, Taiwan, Jan. 03, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, a clinical stage oncology company (4174.TWO), today announced that the ...
Read morePRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 December 2023, 07:00 am CET Pending FDA approval, alfapump could become the first active ...
Read more– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy ...
Read morePress release – No. 18 / 2023 Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in ...
Read moreA playful and easy-to-use application based on cartography NEW DELHI, Dec. 21, 2023 /PRNewswire/ -- The Around.Us application streamlines user ...
Read moreHYDERABAD, India, Dec. 18, 2023 /PRNewswire/ -- In response to the challenges faced by applicants in completing the necessary documentation, the ...
Read moreMAPS incubated the program that generated the first NDA submission for any psychedelic-assisted therapySubmission represents 30-plus years of philanthropy-driven clinical ...
Read moreDenver, CO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rocket Global Forex Ltd is a leading global financial investment service company ...
Read moreMUMBAI, India, Dec. 7, 2023 /PRNewswire/ -- South Indian Bank, one of India's leading private sector banks, extends deadline for ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.